Constantino Michael T. 4
4 · Humacyte, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Constantino Michael T.
Director
Transactions
- Award
Stock Options (right to buy)
2023-06-15+8,500→ 8,500 totalExercise: $3.35Exp: 2033-06-15→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027.